Logo

Ipca Laboratories Share Price

Ipca Laboratories (INR)1632.35-29.6   (-1.8%)

Exchange ScripsBSE524494NSEIPCALABISININE571A01038

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Ipca Laboratories Performance

Market performance
Open price1654
High1672.4
Volumes359313
Prev Close1632.35
Low1621.5
Closing date2025-01-10
Historical performance
1 Year High1755.90
3 Year High1755.90
5 Year High1755.90
1 Year Low1052.00
3 Year Low669.80
5 Year Low581.95

Ipca Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
41151
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
75.66
Dividend Yield
Dividend Yield
0.25 %

Ipca Laboratories Investment Returns

1 Year
46.2%
3 Years
53.9%
5 Years
174.2%
10 Years
342%

Ipca Laboratories Technicals

IndicatorsValueSignal
5-DMA1688.64Bearish
10-DMA1697.34Bearish
20-DMA1635.84Bearish
50-DMA1585.6Bullish
100-DMA1539.96Bullish
200-DMA1397.92Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters1616161616
Foreign Investors---------------
Domestic Investors1616161616
Public Investors9017382959847378114982793
Government---------------

Ipca Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1844151812171292
Operating Profit14484105501379316104
Interest1408482112123
Depreciation3572261623242092
Profit Before Tax842774531135713890
Consolidated Net Profit54734713884111400
Adjusted EPS22193545

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital254254254254
Total Reserves63052581665439546763
Minority Interest13948733769145
Total Non-Current Liabilities10144901761391897
Total Liabilities110970862297621560664
Capital Work in Progress3236122229391837
Total Assets110970862297621560664

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities94478058856110901
Cash Flow from Investing Activities-12918-7250-8550-5207
Cash Flow from Financing Activitie-552550724268-3058
Net Cash Inflow / Outflow-8997588042782636
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 75.66.
  • 3Y Stock Price CAGR of the stock is 15.5.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹14484 Million.
  • The company generated revenue of ₹76624 Million in the previous financial year.

Ipca Laboratories

1632.35-29.6   (-1.8%)

Investment Amount: ₹ 113955
Current Value: ₹ 163235
Performance: 43.2%
P/L: ₹ 49280
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month